PRPH - ProPhase Labs, Inc.
IEX Last Trade
0.6313
0 0%
Share volume: 426
Last Updated: Thu 26 Dec 2024 08:28:51 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$0.63
0.00
0.00%
Fundamental analysis
8%
Profitability
0%
Dept financing
4%
Liquidity
75%
Performance
0%
Performance
5 Days
-0.57%
1 Month
-15.89%
3 Months
-72.25%
6 Months
-85.21%
1 Year
-86.68%
2 Year
-93.37%
Key data
Stock price
$0.63
DAY RANGE
$0.63 - $0.64
52 WEEK RANGE
$0.66 - $7.48
52 WEEK CHANGE
-$86.00
DIVIDEND
$0.30
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Ted W. Karkus
Region: US
Website: prophaselabs.com
Employees: 130
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: prophaselabs.com
Employees: 130
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; Triple Edge XL, an energy and stamina booster. The company was formerly known as The Quigley Corporation.
Recent news